gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · QTRXHealthcareLab Analytical Instruments

Quanterix Corporation Common Stock (QTRX)

$3.04+3.40%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$2.94▼ 44.42% in range
Nov 3, 2025Low $2.42 · High $8.06Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Quanterix closed at $3.04 on Nov 4, up 3.40%, 62.3% below its 52-week closing high. Volume of 402.7K shares was 0.91× its 20-day average (close to normal).

Split-adjusted performance: -11.6% over one month, -7.6% over six months, -42.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $32.91M, up 34.4% from a year earlier, with a net margin of -148.7%.

Short interest was 4.7M shares at the Oct 15 settlement, down 7.3% from the prior report (10.8% of float, 8.4 days to cover).

Market cap$143.8M47.3M shares
Revenue · quarter$32.9M+34.4% YoY
Diluted EPS$-1.04—
P/E · TTM—P/S 0.9×
Net margin-148.7%Gross 38.5%
Dividend yieldNone
52-week range2.42 – 8.06−62.3% from high
Volume402.7K0.91× 20-day avg
Volatility · 60d81.5%Annualised
Short % of float10.8%8.4 days to cover
Net cash$93.5MCash $93.5M
Next earnings—Not scheduled
Split-adjusted performance
1W −2.6%1M −11.6%3M −20.6%6M −7.6%YTD −52.2%1Y −42.5%3Y −85.2%5Y −93.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Lab Analytical Instruments

Percentile among 22 companies (100 = best)

6-month momentum25
Revenue growth95
Net margin24
Value (low P/E)—
Size33

Industry medians: 6-month return +33.8%, revenue growth +4.9%, net margin −19.0%, P/E 38.3×.

Short interest

Details →
Shares short4.7M−7.3% vs prior
Days to cover8.4Settled Oct 15
% of float10.8%
Short vol. 10d44.7%of daily volume

Closest peers by size in Lab Analytical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
QTRXQuanterix$3.04+3.40%−7.6%+34.4%−148.7%—$143.8M
SEERSeer$1.70−1.73%−10.1%−23.4%−544.8%—$94.1MCompare
NAUTNautilus Biotechnolgy$2.29−2.55%−22.1%—−6682.1%—$291.7MCompare
MASS908 Devices$11.07+3.75%+37.3%+23.3%−74.0%—$457.6MCompare
HBIOHarvard Bioscience$8.61−0.69%+18.9%+11.1%−12.8%—$39.2MCompare
PRPOPrecipio$19.57+5.10%−34.7%+24.7%−3.1%—$35.0MCompare
RPIDRapid Micro Biosystems$0.6814−1.53%−73.1%+10.9%−160.5%—$34.2MCompare
EYPTEyePoint$0.3950−1.23%−97.0%−90.5%−18633.1%—$34.1MCompare
CTKBCytek Biosciences$5.88−1.34%+19.0%+5.6%−25.3%—$764.3MCompare

News about Quanterix

All news →

No recent articles focused on Quanterix. 3 articles mention it in passing.

Quick answers

What does Quanterix do?
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory.
What is QTRX's market cap?
$143.77M, based on the Nov 4 close of $3.04.
Does Quanterix pay a dividend?
No regular cash dividend has been paid in the last year.
How much of QTRX is sold short?
4.7M shares, 10.8% of float, as of Oct 15, 2026.
What sector is QTRX in?
Healthcare, in the Lab Analytical Instruments industry.

About Quanterix

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

HQ: Billerica, MA450 employeesListed Dec 7, 2017quanterix.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology